Blood–brain barrier transport of therapeutics via receptor-mediation AR Jones, EV Shusta Pharmaceutical research 24, 1759-1771, 2007 | 662 | 2007 |
Puromycin‐purified rat brain microvascular endothelial cell cultures exhibit improved barrier properties in response to glucocorticoid induction AR Calabria, C Weidenfeller, AR Jones, HE De Vries, EV Shusta Journal of neurochemistry 97 (4), 922-933, 2006 | 185 | 2006 |
Identifying blood–brain‐barrier selective single‐chain antibody fragments AR Jones, CC Stutz, Y Zhou, JD Marks, EV Shusta Biotechnology Journal 9 (5), 664-674, 2014 | 33 | 2014 |
Using a deliberative exercise to foster public engagement in nanotechnology AR Jones, AA Anderson, SK Yeo, AE Greenberg, D Brossard, JW Moore Journal of Chemical Education 91 (2), 179-187, 2014 | 20 | 2014 |
Antibodies and the Blood‐Brain Barrier AR Jones, EV Shusta Therapeutic Monoclonal Antibodies: From Bench to Clinic, 483-502, 2009 | 5 | 2009 |
Blood-brain barrier targeting antibodies EV Shusta, AR Jones, CC Stutz US Patent 9,629,801, 2017 | | 2017 |